C. Chantharakhit, “Efficacy of dose modification of gefitinib after hepatotoxicity in late-line treatment of EGFR mutated advanced non-small cell lung cancer: A case report”, BSCM, vol. 58, no. 2, pp. 99–104, Apr. 2019.